Clene Inc., (NASDAQ: CLNN) is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson’s disease, and multiple sclerosis.
Keynote speaker: Rob Etherington, President / CEO, & Morgan Brown, CFO
![Biden staffers have witnessed at least 15 incidents like horror show debate in last two years, Watergate reporter claims [Video]](https://neurosupportgiving.com/wp-content/uploads/2024/07/mp_236150_0_db5e57f0dbd5dc408ae56c031a03ab0f.jpg)
![Cincinnati Warbirds host World War II aircraft at Lunken Airport [Video]](https://neurosupportgiving.com/wp-content/uploads/2024/07/mp_237672_0_https3A2F2Fdo0bihdskp9dycloudfrontnet2F070420242Ft79b24677a7f042b49a515202ee5a284fnamefile1280x7202000v31jpg.jpg)
![Chris Wiggs dead: British inventor who created Polly Pocket dies aged 74 after rare cancer battle [Video]](https://neurosupportgiving.com/wp-content/uploads/2024/06/mp_233703_0_newspresscollageh20sn9h8e1719610022059jpg.jpg)
![AWS to fund AI-driven medical research to improve child health care [Video]](https://neurosupportgiving.com/wp-content/uploads/2024/06/mp_231376_0_90.png)
